Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Hepalink
AddedFeb 19, 2024
UpdatedJun 28, 2026
Hepalink

Hepalink

Public

Hepalink: A Shenzhen-based pharmaceutical group specializing in heparin products and luxury stationery.

HQ
Shenzhen, Guangdong, CN
Founded
1998
Overview
Compare
Employees
Website

Founded in Shenzhen, Hepalink Pharmaceutical Group Co., Ltd. focuses on the production and distribution of pharmaceutical products, particularly heparin sodium active pharmaceutical ingredients, heparin sodium, and enoxaparin sodium. The company's core mission is to enhance global health through high-quality pharmaceutical solutions. Hepalink also engages in import and export activities, broadening its market focus to international clients.

Notable figures affiliated with Hepalink include key industry experts and seasoned executives in the pharmaceutical sector. The company has achieved significant milestones, such as becoming a leading supplier of heparin products globally. Its impact is evident in the widespread use of its products in critical medical treatments, contributing to advancements in healthcare and patient outcomes worldwide.

Hepalink - Similar Companies

Shenzhen Salubris Pharmaceuticals Co. logo

Shenzhen Salubris Pharmaceuticals Co.

Luye Pharma Group logo

Luye Pharma Group

Betta Pharmaceuticals Co. logo

Betta Pharmaceuticals Co.

bettapharma.com

China PharmaHub logo

China PharmaHub

HighlightLL Pharma logo

HighlightLL Pharma

Zuellig Pharma China logo

Zuellig Pharma China

zuelligpharma.com

Huadong Medicine logo

Huadong Medicine

Haisco logo

Haisco

Yipinhong Pharmacy logo

Yipinhong Pharmacy

Hepanova logo

Hepanova

hepanova.com

Huons Co. logo

Huons Co.

China Grand Pharmaceutical and Healthcare Holdings logo

China Grand Pharmaceutical and Healthcare Holdings

Jianmin Pharmaceutical Group Co logo

Jianmin Pharmaceutical Group Co

Harbin Gloria Pharmaceuticals Co. logo

Harbin Gloria Pharmaceuticals Co.

Sino Biopharmaceutical logo

Sino Biopharmaceutical

Hepalink - Quick Facts

Who are Hepalink's competitors?

Companies similar to Hepalink include Shenzhen Salubris Pharmaceuticals Co., Luye Pharma Group, Betta Pharmaceuticals Co. and China PharmaHub.

When was Hepalink founded?

Hepalink was founded in 1998.

Where is Hepalink's headquarters located?

Hepalink's headquarters is located in Shenzhen, Guangdong, CN.

How many employees does Hepalink have?

Hepalink has 2,046 employees as of Feb 12, 2024.

Hepalink - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Pharmaceuticals
Tags
  • Distribution
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations